Cargando…
A novel quantification platform for point-of-care testing of circulating MicroRNAs based on allosteric spherical nanoprobe
MiRNA-150, a gene regulator that has been revealed to be abnormal expression in non-small cell lung cancer (NSCLC), can be regarded as a serum indicator for diagnosis and monitoring of NSCLC. Herein, a new sort of nanoprobe, termed allosteric spherical nanoprobe, was first developed to sense miRNA-1...
Autores principales: | Tian, Huiyan, Yuan, Changjing, Liu, Yu, Li, Zhi, Xia, Ke, Li, Mengya, Xie, Fengxin, Chen, Qinghai, Chen, Ming, Fu, Weiling, Zhang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603675/ https://www.ncbi.nlm.nih.gov/pubmed/33129342 http://dx.doi.org/10.1186/s12951-020-00717-z |
Ejemplares similares
-
One nanoprobe, two pathogens: gold nanoprobes multiplexing for point-of-care
por: Veigas, Bruno, et al.
Publicado: (2015) -
A Novel and Rapid Serum Detection Technology for Non-Invasive Screening of Gastric Cancer Based on Raman Spectroscopy Combined With Different Machine Learning Methods
por: Li, Mengya, et al.
Publicado: (2021) -
RNA quantification using gold nanoprobes - application to cancer diagnostics
por: Conde, João, et al.
Publicado: (2010) -
Principle Superiority and Clinical Extensibility of 2D and 3D Charged Nanoprobe Detection Platform Based on Electrophysiological Characteristics of Circulating Tumor Cells
por: Chen, Jingyao, et al.
Publicado: (2023) -
Multiplexed detection of SARS-CoV-2 based on upconversion luminescence nanoprobe/MXene biosensing platform for COVID-19 point-of-care diagnostics
por: Song, Menglin, et al.
Publicado: (2022)